HIV Prevention in the Primary Care Setting

NCT00381524 | Completed

• 2 other identifiers: F0402230206 H97HA01191-03-02 (HRSA)
• Study Type: interventional
• Target: 234
• Locations: 1 country
• Sites: 1

Brief Summary

In the third decade of the HIV pandemic, what was once a uniformly and rapidly fatal disease has been transformed into a chronic illness by advances in the understanding of HIV pathogenesis and therapeutics. As a result, HIV-infected individuals are living longer and better lives. This phenomenon, coupled with a continued steady rate of new HIV infections in this country, has led to the highest U.S. HIV prevalence rates since the beginning of the epidemic. In the past, HIV prevention efforts were separate from routine primary care delivery due to multiple factors including stigma and time constraints. Recent events, including increases in sexually transmitted disease (STD) rates among HIV-infected persons and evidence that infected individuals can be super-infected by HIV strains resistant to antiretroviral therapy, have inspired the SPNS program initiative to develop demonstration projects for interventions to reduce risky sexual exposures among HIV-infected patients receiving primary care.

Conditions

Human Immunodeficiency Virus

Keywords

human immunodeficiency virus; behavior change

Outcome Measures

Primary Outcomes (1)

• Proportion of participants reporting 100% condom use preintervention versus post intervention

  End of enrollment

Interventions

Increase condom use BEHAVIORAL

Voluntary increase in condom use

Eligibility Criteria

• Age: 18 Years+
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Active male patients over the age of 16 receiving routine primary care at the 1917 Clinic, reporting sexual contact with another man in the previous 6 months. Active patients will be defined as new patients (patients' first visit) with plans to continue follow-up at 1917 Clinic or an established patient seen at least once during the past year
• Willingness to follow-up for at least 18 months
• Ability to sign informed consent.

You may not qualify if:

• Female patient
• Male patient who is unwilling to follow-up for at least 18 months
• Male patient who is not a primary care patient at the clinic
• Unwillingness or inability to sign informed consent.

Sponsors & Collaborators

• University of Alabama at Birmingham: lead

Study Sites (1)

UAB 1917 Clinic

Birmingham, Alabama, 35294, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV Infections; Blood-Borne Infections; Communicable Diseases; Infections; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Lentivirus Infections; Retroviridae Infections; RNA Virus Infections; Virus Diseases; Slow Virus Diseases; Genital Diseases; Urogenital Diseases; Immunologic Deficiency Syndromes; Immune System Diseases

Study Officials

• Edward W Hook, MD

  University of Alabama at Birmingham

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor of Medicine

Study Record Dates

• First Submitted: September 26, 2006
• First Posted: September 28, 2006
• Study Start: June 1, 2004
• Primary Completion: June 1, 2007
• Study Completion: June 1, 2007
• Last Updated: June 12, 2017

Record last verified: 2009-11

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)